KEYSER D JEFFREY

SEC source: 0001493152-26-023082 · ownership.xml · derivative · entry 2

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,544

Underlying: Common Stock · 48,544 shares

Expires 2031-11-13

F1 · shares: The reported securities were acquired in the issuer's offering of securities that closed on May 14, 2026. The warrants are exercisable commencing on November 14, 2026.

F1 · derivative.exercise_date: The reported securities were acquired in the issuer's offering of securities that closed on May 14, 2026. The warrants are exercisable commencing on November 14, 2026.

SEC source: 0001493152-26-023082 · ownership.xml · nonDerivative · entry 1

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,303

F1 · shares: The reported securities were acquired in the issuer's offering of securities that closed on May 14, 2026. The warrants are exercisable commencing on November 14, 2026.

SEC source: 0001493152-26-002024 · ownership.xml · derivative · entry 2

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,844

Underlying: Common Stock · 28,844 shares

Expires 2036-01-08

F2 · derivative.exercise_date: The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 12-month period commencing February 9, 2026.

SEC source: 0001493152-26-002024 · ownership.xml · derivative · entry 1

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-01-08

F1 · derivative.exercise_date: The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing February 9, 2026.

SEC source: 0001493152-24-029238 · ownership.xml · derivative · entry 2

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,832 shares

Expires 2024-07-25

F1 · kind: On July 24, 2024, the Reporting Person exercised a Series A Warrant to purchase 3,832 shares of common stock at an exercise price of $3.13 per share.

SEC source: 0001493152-24-029238 · ownership.xml · nonDerivative · entry 1

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: On July 24, 2024, the Reporting Person exercised a Series A Warrant to purchase 3,832 shares of common stock at an exercise price of $3.13 per share.

SEC source: 0001493152-24-028184 · ownership.xml · derivative · entry 1

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-07-15

F1 · derivative.exercise_date: The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing August 15, 2024.

SEC source: 0001213900-21-057325 · ownership.xml · derivative · entry 1

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,200

Underlying: Common Stock · 3,200 shares

Expires 2031-11-04

F1 · derivative.exercise_date: The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing upon December 4, 2021.

SEC source: 0001493152-25-014614 · ownership.xml · derivative · entry 4

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,200

Underlying: Common Stock · 3,200 shares

Expires 2031-11-03

F2 · kind: The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 4, 2021 and provides for vesting in equal monthly increments over a 36-month period commencing December 4, 2021.

F2 · derivative.exercise_date: The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 4, 2021 and provides for vesting in equal monthly increments over a 36-month period commencing December 4, 2021.

SEC source: 0001493152-25-014614 · ownership.xml · derivative · entry 3

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,200 shares

Expires 2031-11-03

F2 · kind: The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 4, 2021 and provides for vesting in equal monthly increments over a 36-month period commencing December 4, 2021.

F2 · derivative.exercise_date: The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 4, 2021 and provides for vesting in equal monthly increments over a 36-month period commencing December 4, 2021.

SEC source: 0001213900-20-015034 · ownership.xml · derivative · entry 3

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,135

Underlying: Common Stock · 9,135 shares

Expires not disclosed

F3 · derivative.exercise_price: The Reporting Person was granted options to purchase 9,135 shares of the Issuer's common stock at the exercise price equal to the price per share sold in the Issuer's IPO. The options granted will vest in equal monthly increments over a 36 month period commencing upon the closing of the Issuer's IPO, which is the grant date of the options. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the grant date.

F3 · price: The Reporting Person was granted options to purchase 9,135 shares of the Issuer's common stock at the exercise price equal to the price per share sold in the Issuer's IPO. The options granted will vest in equal monthly increments over a 36 month period commencing upon the closing of the Issuer's IPO, which is the grant date of the options. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the grant date.

F3 · derivative.exercise_date: The Reporting Person was granted options to purchase 9,135 shares of the Issuer's common stock at the exercise price equal to the price per share sold in the Issuer's IPO. The options granted will vest in equal monthly increments over a 36 month period commencing upon the closing of the Issuer's IPO, which is the grant date of the options. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the grant date.

F3 · derivative.expiration_date: The Reporting Person was granted options to purchase 9,135 shares of the Issuer's common stock at the exercise price equal to the price per share sold in the Issuer's IPO. The options granted will vest in equal monthly increments over a 36 month period commencing upon the closing of the Issuer's IPO, which is the grant date of the options. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the grant date.

SEC source: 0001213900-20-015034 · ownership.xml · derivative · entry 2

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 31,927 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: In connection with the IPO, the 18,349 shares of Series A Preferred Stock held by the Reporting Person were automatically converted for no additional consideration into 31,927 shares of common stock immediately prior to the closing of the Issuer's IPO.

F2 · price: In connection with the IPO, the 18,349 shares of Series A Preferred Stock held by the Reporting Person were automatically converted for no additional consideration into 31,927 shares of common stock immediately prior to the closing of the Issuer's IPO.

F2 · derivative.exercise_date: In connection with the IPO, the 18,349 shares of Series A Preferred Stock held by the Reporting Person were automatically converted for no additional consideration into 31,927 shares of common stock immediately prior to the closing of the Issuer's IPO.

F2 · derivative.expiration_date: In connection with the IPO, the 18,349 shares of Series A Preferred Stock held by the Reporting Person were automatically converted for no additional consideration into 31,927 shares of common stock immediately prior to the closing of the Issuer's IPO.

F1 · derivative.underlying_shares: In connection with the Issuer's initial public offering ("IPO"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, which became effective immediately prior to the closing of the Issuer's IPO ("Stock Split"). The share amounts reflect the Stock Split.

F2 · derivative.underlying_shares: In connection with the IPO, the 18,349 shares of Series A Preferred Stock held by the Reporting Person were automatically converted for no additional consideration into 31,927 shares of common stock immediately prior to the closing of the Issuer's IPO.

SEC source: 0001213900-20-015034 · ownership.xml · nonDerivative · entry 1

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,927

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: In connection with the Issuer's initial public offering ("IPO"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, which became effective immediately prior to the closing of the Issuer's IPO ("Stock Split"). The share amounts reflect the Stock Split.

F2 · shares: In connection with the IPO, the 18,349 shares of Series A Preferred Stock held by the Reporting Person were automatically converted for no additional consideration into 31,927 shares of common stock immediately prior to the closing of the Issuer's IPO.

F2 · price: In connection with the IPO, the 18,349 shares of Series A Preferred Stock held by the Reporting Person were automatically converted for no additional consideration into 31,927 shares of common stock immediately prior to the closing of the Issuer's IPO.

F1 · balance_after: In connection with the Issuer's initial public offering ("IPO"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, which became effective immediately prior to the closing of the Issuer's IPO ("Stock Split"). The share amounts reflect the Stock Split.

F2 · balance_after: In connection with the IPO, the 18,349 shares of Series A Preferred Stock held by the Reporting Person were automatically converted for no additional consideration into 31,927 shares of common stock immediately prior to the closing of the Issuer's IPO.

SEC source: 0001493152-25-014614 · ownership.xml · derivative · entry 2

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,135

Underlying: Common Stock · 9,135 shares

Expires 2030-06-14

F1 · kind: The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and provides for vesting in equal monthly increments over a 36-month period commencing July 15, 2020.

F1 · derivative.exercise_date: The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and provides for vesting in equal monthly increments over a 36-month period commencing July 15, 2020.

SEC source: 0001493152-25-014614 · ownership.xml · derivative · entry 1

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,135 shares

Expires 2030-06-14

F1 · kind: The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and provides for vesting in equal monthly increments over a 36-month period commencing July 15, 2020.

F1 · derivative.exercise_date: The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and provides for vesting in equal monthly increments over a 36-month period commencing July 15, 2020.

SEC source: 0001213900-20-015029 · ownership.xml · nonDerivative · entry 1

KEYSER D JEFFREY · CIK 0001393516 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · date: The 10,000 shares of common stock were purchased by the Reporting Person at the offering price $15.00 per share for a total purchase price of $150,000, in connection with Issuer's initial public offering which closed on June 15, 2020. The Reporting Person received notification of the order on June 11, 2020.

F1 · shares: The 10,000 shares of common stock were purchased by the Reporting Person at the offering price $15.00 per share for a total purchase price of $150,000, in connection with Issuer's initial public offering which closed on June 15, 2020. The Reporting Person received notification of the order on June 11, 2020.

F1 · price: The 10,000 shares of common stock were purchased by the Reporting Person at the offering price $15.00 per share for a total purchase price of $150,000, in connection with Issuer's initial public offering which closed on June 15, 2020. The Reporting Person received notification of the order on June 11, 2020.